Ledger.Open graph →
SEC Form D · Amendment · filed October 13, 2020

Stingray Therapeutics, Inc

Offering
$1.5M
Sold
$117K
Exemption
Rule 506(c)
Industry
Biotechnology
Location
HOUSTON, TX
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (9)

Sunil P. Sharma · Houston, TXExec · Director · PromoterJonathan P. Northrup · Houston, TXExec · Director · PromoterScott A. Jordan · Houston, TXExec · Director · PromoterJohn J. Schreiber · Boston, MAExec · Director · PromoterGarth Ebanks · Grand Cayman, Cayman IslandsExec · Director · PromoterJoseph T. Phoenix · Boston, MAExec · Director · PromoterWilliam S. Seybold · San Fransisco, CAExec · Director · PromoterPhilip D. Dreyfuss · San Fransisco, CAExec · Director · Promoter325 Capital LLC · NEW YORK, NYExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗